The shock is in the short term costs, rather than those costs being amortized across the long miserable sickly term of the patients lives. So it's not a show t

The shock is in the short term costs, rather than those costs being amortized across the long miserable sickly term of the patients lives. So it's not a show to the health care system, it's a shock to the system of companies who sit between the health care system and the patients, and siphon out money. I don't knoe about your health insurance, but mine would just declare this drug to be 'not on the formulary' and refuse to pay for it, like they did with the newer anti-clotting meds that were more effecting and safer for patients.